Journal
Cancers
Publication Date
9-22-2022
Volume
14
Issue
19
First Page
4594
Document Type
Open Access Publication
DOI
10.3390/cancers14194594
Rights and Permissions
Shen, Y.; Nussbaum, Y.I.; Manjunath, Y.; Hummel, J.J.; Ciorba, M.A.; Warren, W.C.; Kaifi, J.T.; Papageorgiou, C.; Cortese, R.; Shyu, C.-R.; Mitchem, J.B. TBX21 Methylation as a Potential Regulator of Immune Suppression in CMS1 Subtype Colorectal Cancer. Cancers 2022, 14, 4594. https://doi.org/10.3390/cancers14194594 This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Recommended Citation
Shen, Yuanyuan; Nussbaum, Yulia I; Manjunath, Yariswamy; Hummel, Justin J; Ciorba, Matthew A; Warren, Wesley C; Kaifi, Jussuf T; Papageorgiou, Christos; Cortese, Rene; Shyu, Chi-Ren; and Mitchem, Jonathan B, "TBX21 methylation as a potential regulator of immune suppression in CMS1 subtype colorectal cancer." Cancers. 14, 19. 4594 (2022).
https://digitalcommons.wustl.edu/oa_4/925
Additional Links
Supplemental material is available for this article at publisher site.
